Literature DB >> 8996481

African Americans and women have the highest stroke mortality in Texas.

L B Morgenstern1, W D Spears, D C Goff, J C Grotta, M Z Nichaman.   

Abstract

BACKGROUND AND
PURPOSE: Hispanic American (HA), African American (AA), and non-Hispanic white (NHW) populations are well represented in Texas. The Texas HA population is 95% Mexican American, affording comparison with other Hispanic populations. From risk factor profiles we expected stroke mortality to be highest in AAs and HAs. We also expected stroke mortality to be considerably higher for men than for women based on previous data.
METHODS: We used International Classification of Diseases, 9th Revision, codes 430 to 438 to search Texas vital statistics data for the 5-year period from 1988 through 1992. Race/ethnic differences are presented in age- and sex-specific format to avoid masking the important interaction of age and sex with stroke mortality.
RESULTS: Women constituted 61% of the 40,346 stroke deaths in Texas during this period. The ratio of stroke deaths for women versus men approximates the ratio of women to men in the population. AAs had a threefold to fourfold increased stroke mortality relative to NHWs at young ages. At older ages, when stroke mortality is the highest, the stroke mortality rate in NHWs approached the stroke mortality rate of AAs. HAs had a significantly higher rate of stroke mortality at younger ages relative to NHWs but a significantly lower rate at older ages.
CONCLUSIONS: Measures to prevent stroke mortality should emphasize its predilection for young AAs and women. A rigorous surveillance project is needed to determine whether stroke mortality is underestimated in the HA population.

Entities:  

Mesh:

Year:  1997        PMID: 8996481     DOI: 10.1161/01.str.28.1.15

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Preventing recurrence of thromboembolic events through coordinated treatment in the District of Columbia.

Authors:  Alexander W Dromerick; Michael C Gibbons; Dorothy F Edwards; Deeonna E Farr; Margot L Giannetti; Brisa Sánchez; Nawar M Shara; Ali Fokar; Annapurni Jayam-Trouth; Bruce Ovbiagele; Chelsea S Kidwell
Journal:  Int J Stroke       Date:  2011-10       Impact factor: 5.266

2.  Race, Marital History, and Risks for Stroke in US Older Adults.

Authors:  Matthew E Dupre
Journal:  Soc Forces       Date:  2016-08-11

3.  Effect of sex on outcome after recurrent stroke in African Americans: results from the African American Antiplatelet Stroke Prevention Study.

Authors:  Fernando D Testai; John F Cursio; Philip B Gorelick
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-05-04       Impact factor: 2.136

4.  Are there differences in risk factor profiles and frequency of CT/MRI-based infarcts among African American stroke patients with and without hypertension? A report from the African American Antiplatelet Stroke Prevention Study (AAASPS).

Authors:  Chandra Y Whittley; Philip B Gorelick; Rema Raman; Jeffrey Harris; DeJuran Richardson
Journal:  J Natl Med Assoc       Date:  2003-06       Impact factor: 1.798

5.  Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project.

Authors:  Lewis B Morgenstern; Melinda A Smith; Lynda D Lisabeth; Jan M H Risser; Ken Uchino; Nelda Garcia; Paxton J Longwell; David A McFarling; Olubumi Akuwumi; Areej Al-Wabil; Fahmi Al-Senani; Devin L Brown; Lemuel A Moyé
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

6.  Ischemic heart disease and stroke mortality in African-American, Hispanic, and non-Hispanic white men and women, 1985 to 1991.

Authors:  A J Karter; J M Gazzaniga; R D Cohen; M L Casper; B D Davis; G A Kaplan
Journal:  West J Med       Date:  1998-09

Review 7.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.